Guaifenesin
Guaifenesin
Guaifenesin
Pediatric
o Children 6 months to 2 years: 25-50 mg every 4 hours; not to exceed 300
mg/day
o Children 2-6 years: 50-100 mg orally every 4 hours; not to exceed 600
mg/day
o Children 6-11 years: 100-200 mg orally every 4 hours; not to exceed 1.2
g/day
o Children older than 12 years
100-400 mg orally every 4 hours; not to exceed 2.4 g/day, OR
1-2 extended-release tablets (600-1200 mg) orally every 12 hours;
not to exceed 4 tablets/24 hours (2.4 g/day)
Contraindications
General Information
o Guaifenesin may alter some laboratory tests. It may increase renal
clearance for urate and lower serum uric acid levels.
o Guaifenesin may also falsely elevate the VMA test for catechols.
o Guaifenesin should be discontinued at least 48 hours prior to the
collection of urine specimens for such laboratory tests.
Asthma, bronchitis, emphysema, heart failure, tobacco smoking
o Guaifenesin should not be used for a cough that is specifically associated
with heart failure or ACE inhibitor therapy.
Fever
Pregnancy
Breast-feeding
Geriatric
Brand Names
US Brand Names
o Allfen
o Altarussin
o Amibid LA
o Antitussin
o Bidex 400
o Diabetic Siltussin DAS-Na
o Diabetic Tussin EX
o Drituss G
o Guaifenex G
o Guaifenex LA
o Mucinex
o Robitussin
Canadian Brand Names
o Balminil Expectorant
o Balminil Expectorant Sugar-Free
o Benylin-E
o Benylin E Extra Strength Chest Congestion
o Broncho-Grippex Expectorant
o Resyl
o Robitussin Extra Strength
Pharmacodynamics
Absorption - Studies have shown that guaifenesin is well absorbed from and along the
gastrointestinal tract after oral administration
Metabolism - After the oral administration of 400 mg guaifenesin, the agent experiences rapid
hydrolysis (more than 60% of the dose hydrolyzed over a range of seven hours) with β-(2-
methoxyphenoxy)-lactic acid found as the major urinary metabolite but no parent drug
detectable in the urine 5,7. Moreover, it has been observed that guaifenesin also experiences
both oxidation and demethylation 5. In particular, the medication is quickly metabolized
hepatically by way of oxidation to β-(2-methoxyphenoxy)-lactic acid 5. Furthermore, guaifenesin
is also demethylated by O-demethylase in liver microsomes to the point where about 40% of an
administered dose is excreted as this metabolite in the urine within 3 hours 5. In fact, O-
demethylase appears to be the primary enzyme for the metabolism of guaifenesin and the
primary metabolites of the substance are β-(2-methoxyphenoxy)-lactic acid and the
demethylated hydroxyguaifenesin, both of which are themselves inactive moieties 5.
Elimination - After administration, guaifenesin is metabolized and then largely excreted in the
urine.
References:
Guaifenesin (Oral Route) Description and Brand Names - Mayo Clinic . (2022).
Retrieved 22 November 2022, from https://www.mayoclinic.org/drugs-
supplements/guaifenesin-oral-route/description/drg-
20068720#:~:text=Guaifenesin%20is%20used%20to%20help,or%20phlegm
%20in%20the%20lungs.
(2022). Retrieved 22 November 2022, from
https://www.rxlist.com/consumer_guaifenesin_mucinex/drugs-condition.htm
Mucinex (guaifenesin) dose, indications, adverse effects, interactions... from
PDR.net . (2022). Retrieved 22 November 2022, from https://www.pdr.net/drug-
summary/Mucinex-guaifenesin-1275#:~:text=Guaifenesin%20should%20not
%20be%20used,of%20a%20health%20care%20professional.
Guaifenesin: Uses, Interactions, Mechanism of Action | DrugBank Online. (2022).
Retrieved 22 November 2022, from https://go.drugbank.com/drugs/DB00874